Executive Director and Global Head, CMC Policy, Merck & Co., Inc., United States
Christine Moore is Global Head and Executive Director, CMC Policy at Merck. Christine joined Merck after more than a decade in various positions in the US FDA. Prior to working at FDA, Christine spent 10 years in small and large molecule process development. Throughout her career...
Read More →
Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector), Medicines and Healthcare products Regulatory Agency (MHRA)
David Churchward has been a GMP inspector with the UK MHRA since 2004 and is responsible for the strategic direction of the GxP inspectorate. He is experienced in leading the implementation of innovative regulatory approaches and provides GMP input to the MHRA’s Innovation Office...
Read More →
Senior Program Management Officer, Drug Shortage Staff, CDER, FDA
Jeannie David has been with the Drug Shortage Staff since 2012 and has worked on several drug shortage mitigation efforts, as well as on the Guidance to Industry Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing, MAPP 5001.1 Drug Product Distribution After...
Read More →
Deputy Executive Director, European Medicines Agency
Noël Wathion is the Deputy Executive Director of the EMA since February 2016. He is also the Chief of Policy. He joined the Agency in 1996, and has since held several senior managerial positions, including Head of the Post-Authorisation Evaluation of Medicines for Human Use Unit...
Read More →
